Gilead Sciences | 64.4700 / -0.83% |
Date/Time | 05/26 / 22:00 |
Chg. / Chg.(%) | -0.5400 / -0.83% |
Bid | 64.2800 / 300 |
Ask | 64.4000 / 100 |
Open | 65.1600 |
Previous Close | 65.0100 |
High | 65.4600 |
Low | 64.4600 |
Volume [USD] | 292,374,615.2946 |
Volume [Units] | 5,730,796 |
Price fixings | 22543 |
ISIN | US3755581036 |
Security | GILD |
Exchange | NASDAQ |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
TradeGate | 60.190 | ![]() |
50 |
Frankfurt | 59.9100 | ![]() |
0 |
Berlin | 59.92 | ![]() |
0 |
Hannover | 59.90 | ![]() |
0 |
München | 60.18 | ![]() |
0 |
Düsseldorf | 59.84 | ![]() |
0 |
Hamburg | 59.90 | ![]() |
0 |
Lang & Schwa.. | 59.910 | ![]() |
|
Stuttgart | 59.970 | ![]() |
|
gettex | 60.050 | ![]() |
|
Quotrix | 60.0300 | ![]() |
|
NASDAQ | 64.4700 | ![]() |
5,730,796 |
Cboe US | 64.48 | ![]() |
466,026 |
IEX | 64.47 | ![]() |
138,830 |
Xetra | 60.66 | ![]() |
1,689 |
London Inter.. | 65.09 | 1,318 | |
Euronext Mil.. | 61.00 | ![]() |
151 |
Vienna Globa.. | 60.75 | ![]() |
45 |
Mexico | 1,272.33 | ![]() |
30 |
Euronext Mil.. | 57.98 | ![]() |
4 |
News
- Gilead's revenues up 3% to $6.6B in Q1
04/28/2022 / 22:04 - TeleTrader - Jyseleca® approved in Japan for ulcerative colitis
03/28/2022 / 08:01 - GlobeNewswire - C4 Therapeutics Appoints Utpal Koppikar to Board of Directors
03/16/2022 / 21:05 - GlobeNewswire - Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
03/14/2022 / 12:00 - GlobeNewswire - Gritstone Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Corporate Updates
03/10/2022 / 22:05 - GlobeNewswire